Abstract:Esophageal squamous cell carcinoma (ESCC) is a prevalent cancer with high morbidity and mortality worldwide. Radiotherapy is one major curative treatment modality for ESCC. Herein, our study aimed to investigate whether CAFs (cancer-associated fibroblasts), a main component of tumor microenvironment, were involved in mediating the development of radioresistance and further explored the mechanisms underlying CAFs-mediated radioresistance in ESCC. By primary culture, two pairs of CAFs and matched NFs (normal fibroblasts) had been successfully isolated from tumor tissues of ESCC patients and matched normal esophageal epithelial tissues, respectively. The secretion of chemokines by CAFs and matched NFs was determined by the human chemokine antibody array. The concentrations of chemokine in culture medium of CAFs, matched NFs and ESCC cells were determined by Elisa assay. The effect of CAFs-secreted chemokines on radioresistance was investigated in vitro by clonogenic survival assay, detection of DNA double-strand breaks (DSBs) and by flow cytometry analysis on cell apoptosis. By establishment of xenograft tumor models in BALB/c nude mice, the effect of CAFs on radioresistance was investigated in vivo. CAFs conferred ESCC cells KYSE-30 and KYSE-150 significant radioresistance by promoting clonogenic survival and inhibiting DSBs and cell apoptosis following radiation in comparison with their matched NFs. Mechanism studies revealed that human chemokine CXCL1 (The chemokine [C-X-C motif] ligand 1) was secreted by CAFs at a significantly higher level compared with matched NFs and ESCC cells. Inhibition of CXCL1 expression in CAFs by the human specific antibody against CXCL1 significantly reversed CAFs-mediated radioresistance by enhancing radiation-induced DSBs, and inhibiting DNA damage repair response and the activation of anti-apoptotic Mek/Erk signaling pathway. The use of CXCL1 antibody also significantly reversed CAFs-mediated radioresistance in xenograft tumor models. Further studies demonstrated that CAFs-secreted CXCL1 suppressed the expression of antioxidant enzyme SOD1 (superoxide dismutases), leading to accelerated ROS (Reactive Oxygen Species) accumulation which activated DNA damage repair response and mediated the radioresistance. Moreover, the crosstalk of CAFs and ESCC cells induced CXCL1 expression in an autocrine/paracrine signaling loop by which the radioresistance was further enhanced. Our study for the first time discovered CAFs-secreted CXCL1 as an attractive target to reverse the radioresistance of ESCC.

The AEG-1-USP10-PARP1 Axis Confers Radioresistance in Esophageal Squamous Cell Carcinoma Via Facilitating Homologous Recombination-Dependent DNA Damage Repair.

CAFs-Secreted CXCL1 Mediated Radioresistance by Regulating DNA Damage Response in an ROS-Dependent Manner in Esophageal Squamous Cell Carcinoma

AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma

EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway

Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells

ZNF468 inhibits irradiation-induced G2/M cell cycle arrest and apoptosis by facilitating AURKA transcription in Esophageal Squamous Cell Carcinoma

The ATPase Subunit of ATP6V1C1 Inhibits Autophagy and Enhances Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

Overexpression of Astrocyte Elevated Gene-1 (Aeg-1) is Associated with Esophageal Squamous Cell Carcinoma (escc) Progression and Pathogenesis

TMT‐Based Quantitative Proteomic Profiling of Human Esophageal Cancer Cells Reveals the Potential Mechanism and Potential Therapeutic Targets Associated With Radioresistance

Polymerase Iota (POLI) Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating RAD51 Stability and Facilitating Homologous Recombination.

PI3Kα Inhibitors Sensitize Esophageal Squamous Cell Carcinoma to Radiation by Abrogating Survival Signals in Tumor Cells and Tumor Microenvironment.

PD-1 Inhibitor Enhanced Radiosensitivity by Reactivating T Cells and Inducing G2/M Phase Arrest in Esophageal Squamous Cell Carcinoma

MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma

A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer

PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1

Effects and Underlying Mechanisms of Homologous Recombina-Tion-associated Protein XRCC3 on Esophageal Squamous-Cell Carci-Noma Radiotherapy Response

USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase